378
Notably, the researchers highlight the treatment’s potential not only to address symptoms but also to target the root causes of neurodegeneration. This comprehensive approach distinguishes the new therapy from existing treatments that primarily offer symptomatic relief.
The next steps involve rigorous clinical trials to assess the treatment’s safety and efficacy in human subjects. Pharmaceutical collaborations and funding partnerships are already underway to expedite the transition from the laboratory to practical applications.